1.
Rischin D, Khushalani N, Schmults C, Guminski A, Chang AL, Lewis K, Lim A, Hernandez-Aya L, Hughes B, Schadendorf D, Hauschild A, Stankevich E, Booth J, Yoo S-Y, Chen Z, Okoye E, Lowy I, Fury M, Migden M. Phase 2 Study of Cemiplimab in Patients with Advanced Cutaneous Squamous Cell Carcinoma (CSCC): Longer Follow-Up. J of Skin [Internet]. 2020Oct.27 [cited 2021Jan.18];4(6):s124. Available from: https://jofskin.org/index.php/skin/article/view/1097